Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - THURSDAY, DECEMBER 27TH, 2012
Previous Mid Day Report Next Mid Day Report >>>

DOW 13004.28 -110.31 (-0.84%) | NASDAQ 2959.02 -31.14 (-1.04%) | S&P 500 1405.77 -14.36 (-1.01%)
Time of Screening : 12/27/2012 12:04:05 PM         Report Released : 12/27/2012 12:34:37 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
NSR - NYSE
Neustar Inc
$40.78 -1.35
-3.20%
$42.26 560,395
154.89% of 50 DAV
50 DAV is 361,800
$43.85
-7.00%
12/11/2012 $41.85 PP = $41.41
MB = $43.48
Most Recent Note - 12/27/2012 12:18:39 PM
Y - Raising concerns with above average volume behind today's damaging loss, yet it is up from earlier lows near its 50 DMA line. A finish in the upper third of its intra-day range would be an encouraging sign it is attracting prompt support, but a finish near the session lows and below its old high close ($41.05 on 10/05/12), completely negating its recent breakout, would be a worrisome sign.
>>> The latest Featured Stock Update with an annotated graph appeared on 12/11/2012. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
CBPO - NASDAQ - DRUGS - Biotechnology
China Biologic Products
$15.98 +0.50
3.20%
$16.00 $16.00 -0.13% 74,718
261.25%
28,600
Most Recent Note for CBPO - 12/27/2012 12:05:33 PM
Hit a new 52-week high today with a volume-driven gain. Prior mid-day reports repeatedly noted - "It is extended from any sound base pattern following a recent spurt of volume-driven gains. Recent quarterly comparisons through Sep '12 satisfy the C criteria, but waning annual earnings increases in FY '10 and '11 are a flaw concerning the A criteria. It survived but failed to impress since noted in the 2/03/11 mid-day report - 'The China-based Medical - Biomed/Biotech firm has earned high ranks, but it sales and earnings increases have been erratic and below the fact-based investment system's guidelines.'"
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
DRD - NYSE - METALS & MINING - Gold
Drdgold Ltd Adr
$7.59 +0.20
2.71%
$7.61 $8.16 -6.99% 45,308
78.66%
57,600
Most Recent Note for DRD - 12/27/2012 12:07:49 PM
Recently found support near its 50 DMA line and it is trading -7% off its 52-week high today with volume running at an above average pace behind its gain. Went through a deep consolidation below its 200 DMA line then rebounded since noted in the 3/01/12 mid-day report - "This low-priced South African company in the Mining - Gold/Silver/Gems group has an erratic earnings history, not a match with the fact-based investment system's guidelines."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HOLI - NASDAQ - MANUFACTURING - Industrial Electrical Equipmen
Hollysys Automation Tech
$11.67 +0.36
3.18%
$11.73 $11.73 -0.51% 224,481
75.38%
297,800
Most Recent Note for HOLI - 12/27/2012 12:10:58 PM
The China-based firm is hitting a new 52-week high with today's 2nd consecutive gain adding to its recent spurt of volume-driven gains. Reported earnings +22% on +1% sales for the Sep '12 quarter, below the +25% minimum earnings (C criteria) guideline for buy candidates. Prior mid-day reports repeatedly cautioned members - "Additional overhead supply remains to act as resistance up through the $18 level. Recent quarters through Jun '12 showed mostly strong earnings increases."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NUTR - NASDAQ - DRUGS - Drug Related Products
Nutraceutical Intl Corp
$16.08 -0.35
-2.13%
$16.40 $17.10 -5.96% 16,971
68.16%
24,900
Most Recent Note for NUTR - 12/27/2012 12:21:25 PM
Fundamentals (C and A criteria) are not a match with the fact-based investment system's guidelines today. It hit new 52-week high territory with recent volume-driven gains following a special dividend. The 12/19/12 mid-day report noted - "It survived but failed to impress since last noted in the 8/06/12 mid-day report - 'It has built a long flat base-on-base type pattern. Fundamentals are below guidelines of the investment system today for this vitamin and dietary supplement maker which was long ago (back in 2004) on the Featured Stocks list.'"
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RUK - NYSE - MEDIA - Publishing - Newspapers
Reed Elsevier Plc Adr
$41.36 -0.07
-0.17%
$41.57 $42.21 -2.01% 15,808
59.88%
26,400
Most Recent Note for RUK - 12/27/2012 12:24:08 PM
Holding its ground above prior highs and above its 50 DMA line defining near-term support in the $40 area while consolidating after recently wedging to new 52-week and multi-year highs with gains lacking great volume conviction. No resistance remains due to overhead supply, however prior mid-day reports noted - "This British Media - Periodicals firm does not have an earnings history matching the fact-based investment system's winning models."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SXI - NYSE - CONGLOMERATES - Conglomerates
Standex Intl Corp
$49.94 +0.52
1.05%
$49.94 $52.14 -4.22% 18,526
58.44%
31,700
Most Recent Note for SXI - 12/27/2012 12:25:29 PM
Consolidating only -4.8% off its 52-week high today. Reported earnings +12% on +15% sales revenues for the quarter ended Sep 30, 2012 versus the year ago period. Prior mid-day reports repeatedly cautioned members- "Its sales and earnings history in recent quarterly comparisons has shown growth borderline or below the fact-based investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TM - NYSE - AUTOMOTIVE - Auto Manufacturers - Major
Toyota Motor Corp Adr
$91.85 +1.49
1.65%
$92.17 $92.69 -0.91% 267,121
79.22%
337,200
Most Recent Note for TM - 12/27/2012 12:26:51 PM
Holding its ground stubbornly while perched near its 52-week high. Prior mid-day reports cautioned members - "Erratic earnings history is not a match with the fact-based investment system's guidelines. Gapped up again today for a 3rd consecutive session and another new 52-week high after technically breaking out from an orderly base on 12/18/12 with a solid gap up gain."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TRIB - NASDAQ - DRUGS - Diagnostic Substances
Trinity Biotech Plc Adr
$14.21 -0.39
-2.67%
$14.63 $15.75 -9.78% 53,301
65.72%
81,100
Most Recent Note for TRIB - 12/27/2012 12:29:43 PM
Violating its 50 DMA line and slumping under prior highs with a damaging loss today. It has been slumping due to distributional pressure since last noted in the 12/06/12 mid-day report - "Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (A criteria) showed steady increases since a downturn in FY '08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, 'How To Make Money In Stocks'. The past 9 quarterly earnings comparisons through Sep '12 were below the +25% minimum guideline of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TTS - NASDAQ - RETAIL - Home Improvement Stores
Tile Shop Holdings Inc
$16.97 +0.10
0.59%
$17.44 $17.56 -3.36% 122,641
64.31%
190,700
Most Recent Note for TTS - 12/27/2012 12:30:50 PM
Perched near its 52-week high and holding its ground while poised today for a best-ever close. Showing resilience after pricing a Secondary Offering on 12/12/12. The Sep '12 quarter showed greatly improved earnings, but it was noted in prior mid-day reports with caution - "Earnings history is not a match with the fact-based investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us